Saban R, Capaz F R, De Moraes S
Eur J Pharmacol. 1982 Aug 13;82(1-2):37-45. doi: 10.1016/0014-2999(82)90550-7.
Long-term treatment with sodium barbital did not alter significantly the responsiveness of the isolated rat vas deferens to noradrenaline. However, three days after barbital withdrawal there was a 4.5-fold increase in the sensitivity and an enhanced maximum response to the neurotransmitter. Pharmacological analysis of the affinity of postjunctional adrenoceptors showed no alteration of the pA2 of phentolamine, a decrease in the apparent dissociation constant (KA) for noradrenaline and an increase in the fraction of adrenoceptors (q) remaining active after exposure to phenoxybenzamine. Comparison between ED50 and KA indicates the presence of spare receptors in the rat vas deferens. There was also a decrease in the blocking activity of phenoxybenzamine, in vasa deferentia obtained from rats three days after barbital withdrawal. These results suggest that an increased affinity of postjunctional adrenoceptors could be responsible, at least partially, for this supersensitivity to noradrenaline. The increased maximum response to the neurotransmitter could be the consequence of an improved coupling of adrenoceptor occupation to the final contractile response.
长期使用巴比妥钠治疗并未显著改变离体大鼠输精管对去甲肾上腺素的反应性。然而,在停用巴比妥钠三天后,对该神经递质的敏感性增加了4.5倍,最大反应增强。对节后肾上腺素能受体亲和力的药理学分析表明,酚妥拉明的pA2没有改变,去甲肾上腺素的表观解离常数(KA)降低,暴露于酚苄明后仍保持活性的肾上腺素能受体分数(q)增加。ED50与KA的比较表明大鼠输精管中存在备用受体。在停用巴比妥钠三天后的大鼠输精管中,酚苄明的阻断活性也有所降低。这些结果表明,节后肾上腺素能受体亲和力的增加可能至少部分地导致了对去甲肾上腺素的这种超敏反应。对神经递质最大反应的增加可能是肾上腺素能受体占据与最终收缩反应之间耦合改善的结果。